Related references
Note: Only part of the references are listed.Non-coding RNA networks in cancer
Eleni Anastasiadou et al.
NATURE REVIEWS CANCER (2018)
The chemical evolution of oligonucleotide therapies of clinical utility
Anastasia Khvorova et al.
NATURE BIOTECHNOLOGY (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Breast cancer statistics, 2017, racial disparity in mortality by state
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Complex Coacervation-Integrated Hybrid Nanoparticles Increasing Plasmid DNA Delivery Efficiency in Vivo
Yunfei Li et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues
Saeid Zanganeh et al.
NATURE NANOTECHNOLOGY (2016)
A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer
Simon B. Zeichner et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2016)
Targeting metabolism in breast cancer: How far we can go?
Jing-Pei Long et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2016)
Targeting tumor metastases: Drug delivery mechanisms and technologies
Vidya Ganapathy et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases
Yu-Cheng Tseng et al.
BIOMATERIALS (2014)
Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles
Yang Liu et al.
BIOMATERIALS (2014)
Small-sized polymeric micelles incorporating docetaxel suppress distant metastases in the clinically-relevant 4T1 mouse breast cancer model
Yunfei Li et al.
BMC CANCER (2014)
MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis
Brock Humphries et al.
CARCINOGENESIS (2014)
Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling
Fei Ma et al.
GENE (2014)
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
Brian D. Lehmann et al.
JOURNAL OF PATHOLOGY (2014)
Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
W. Kong et al.
ONCOGENE (2014)
Unraveling the mysteries of serum albumin-more than just a serum protein
Angelica M. Merlot et al.
FRONTIERS IN PHYSIOLOGY (2014)
Lymphangiogenesis and lymphatic vessel remodelling in cancer
Steven A. Stacker et al.
NATURE REVIEWS CANCER (2014)
Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
Zhou J. Deng et al.
ACS NANO (2013)
Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles
Qin Lin et al.
BIOMATERIALS (2013)
Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy
Yuan Zhang et al.
BIOMATERIALS (2013)
Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles
Feifei Yang et al.
BIOMATERIALS (2013)
AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial-Mesenchymal Transition and Suppresses Tumor Growth and Progression
Zhendong Shi et al.
CANCER RESEARCH (2013)
Polymeric micelles for enhanced lymphatic drug delivery to treat metastatic tumors
Lei Qin et al.
JOURNAL OF CONTROLLED RELEASE (2013)
17β-Estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells
Chunmei Zhang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
被撤回的出版物: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells (Retracted article. See vol. 12, art no e0175869, 2017)
Rounak Nassirpour et al.
PLOS ONE (2013)
Imaging Metastasis Using an Integrin-Targeting Chain-Shaped Nanoparticle
Pubudu M. Peiris et al.
ACS NANO (2012)
Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation
Nivedita Banerjee et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Lin28 regulates HER2 and promotes malignancy through multiple mechanisms
Chen Feng et al.
CELL CYCLE (2012)
Phase II Trial of Nab-Paclitaxel Compared With Docetaxel as First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Final Analysis of Overall Survival
William J. Gradishar et al.
CLINICAL BREAST CANCER (2012)
Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis
Md Rafi et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor
Jun Li et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Effect of Inhibition of the Lysophosphatidic Acid Receptor 1 on Metastasis and Metastatic Dormancy in Breast Cancer
Jean-Claude A. Marshall et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
Michela Garofalo et al.
NATURE MEDICINE (2012)
Strategies for the discovery and development of therapies for metastatic breast cancer
Bedrich L. Eckhardt et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Survivin expression and targeting in breast cancer
Kumkum Jha et al.
SURGICAL ONCOLOGY-OXFORD (2012)
Treating metastatic cancer with nanotechnology
Avi Schroeder et al.
NATURE REVIEWS CANCER (2012)
Dextran-Coated Iron Oxide Nanoparticles: A Versatile Platform for Targeted Molecular Imaging, Molecular Diagnostics, and Therapy
Carlos Tassa et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy Preface
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Detection of Macrophages in Aortic Aneurysms by Nanoparticle Positron Emission Tomography-Computed Tomography
Matthias Nahrendorf et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA
Mark Mackiewicz et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM
Y. Wang et al.
ONCOGENE (2011)
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Cliff Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Triple negative breast cancer - prognostic factors and survival
Tanja Ovcaricek et al.
RADIOLOGY AND ONCOLOGY (2011)
Promoting Convergence in Biomedical Science
Phillip A. Sharp et al.
SCIENCE (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Photodynamic Ablation of Lymphatic Vessels and Intralymphatic Cancer Cells Prevents Metastasis
Tuomas Tammela et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Synergy of Nab-paclitaxel and Bevacizumab in Eradicating Large Orthotopic Breast Tumors and Preexisting Metastases
Lisa D. Volk et al.
NEOPLASIA (2011)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery
Jun Li et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
Anna Maria Calcagno et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Delivering nanomedicine to solid tumors
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Does tumour dormancy offer a therapeutic target?
Paul E. Goss et al.
NATURE REVIEWS CANCER (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
Lipidic Systems for In Vivo siRNA Delivery
Sherry Y. Wu et al.
AAPS JOURNAL (2009)
Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells
Ryosuke Moriai et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Significantly Longer Progression-Free Survival With nab-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer
William J. Gradishar et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
Mark E. Davis
MOLECULAR PHARMACEUTICS (2009)
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Joseph Lehar et al.
NATURE BIOTECHNOLOGY (2009)
siRNA and Innate Immunity
Marjorie Robbins et al.
OLIGONUCLEOTIDES (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes
Masahiko Tanabe et al.
BREAST CANCER (2009)
Chemically modified siRNA: tools and applications
Jonathan K. Watts et al.
DRUG DISCOVERY TODAY (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
Manav Korpal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Advances in the treatment of breast cancer
S. Moulder et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
Cancer stem cells in solid tumors
Laurie E. Ailles et al.
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Immunological properties of engineered nanomaterials
Marina A. Dobrovolskaia et al.
NATURE NANOTECHNOLOGY (2007)
Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin
Ning Tang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition
Elizabeth Buck et al.
MOLECULAR CANCER THERAPEUTICS (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells
Shyh-Dar Li et al.
MOLECULAR PHARMACEUTICS (2006)
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
A. Santel et al.
GENE THERAPY (2006)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
WJ Gradishar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7
V Hornung et al.
NATURE MEDICINE (2005)
Extending survival with chemotherapy in metastatic breast cancer
J O'Shaughnessy
ONCOLOGIST (2005)
Transgenic mouse model for breast cancer:: induction of breast cancer in novel oncogene HCCR-2 transgenic mice
JS Ko et al.
ONCOGENE (2004)
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
MER O'Brien et al.
ANNALS OF ONCOLOGY (2004)
Relationship between antiapoptotic molecules and metastatic potency and the involvement of DNA-dependent protein kinase in the chemosensitization of metastatic human cancer cells by epidermal growth factor receptor blockade
JH Um et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery
NC Bellocq et al.
BIOCONJUGATE CHEMISTRY (2003)
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
MG Harisinghani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases
GN Naumov et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
